ArticleHNO2026
[Voice-related quality of life and emotional distress in functional dysphonia during the COVID-19 pandemic].
Article in HNO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic led to physical illness, mental health disorders, social problems, and ongoing societal conflicts that have not yet been entirely resolved. Among the inflammatory processes associated with the virus, organic otorhinolaryngologic diseases occurred, resulting in functional impairments such as voice disorders caused by laryngeal affections. This study focused on the subjective suffering caused by functional dysphonia during the pandemic in patients who had not been affected by COVID-19. The underlying assumption was that the overall pandemic situation would alter both the healthcare-seeking behavior of affected individuals as well as their subjective assessments compared to the periods before and after the pandemic. MATERIALS AND
methodsThe study was based on clinical routine data collected from the phoniatric and pedaudiologic specialist practice of the second author covering the second quarter of 2019 through to the second quarter of 2023. A total of 972 adult patients who presented for the first time with functional dysphonia were included. Assessment tools were the Voice-Related Quality of Life (VRQoL) questionnaire and the Depression Anxiety Stress Scales (DASS) that measure depression, anxiety, and stress.
resultsIn the quarter preceding the first lockdown, the number of patients was higher than the average of all other quarters, while it was lower during the quarter of the first lockdown. For the remainder of the observation period, patient numbers fluctuated without statistical significance. Across all measured domains, no significant differences were observed when comparing the periods before and after the pandemic.
conclusionNo pandemic-related changes were found in the subjective experience of suffering from functional dysphonia, neither in terms of voice-specific dysfunction nor in emotional domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.